Works matching IS 10837159 AND DT 2013 AND VI 18 AND IP 1
Results: 26
'Well, I Think There Is Great Variation...': A Qualitative Study of Oncologists' Experiences and Views Regarding Medical Criteria and Other Factors Relevant to Treatment Decisions in Advanced Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel-Agent-Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real-World Claims Data.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Hand-Schüller-Christian Disease and Erdheim-Chester Disease: Coexistence and Discrepancy.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Erlotinib and Gefitinib, Epidermal Growth Factor Receptor Kinase Inhibitors, May Treat Non-Cancer-Related Tumor Necrosis Factor-α Mediated Inflammatory Diseases.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. e3, doi. 10.1634/theoncologist.2012-0219
- By:
- Publication type:
- Article
In Reply.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Reply to: Gilligan T. Is There Such a Thing as Cancer Treatment That Isn't Worth Its Cost? The Oncologist 2012;17:3-4.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Nutrient Restriction and Radiation Therapy for Cancer Treatment: When Less Is More.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 97, doi. 10.1634/theoncologist.2012-0164
- By:
- Publication type:
- Article
"Well, I Think There Is Great Variation...": A Qualitative Study of Oncologists' Experiences and Views Regarding Medical Criteria and Other Factors Relevant to Treatment Decisions in Advanced Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 90, doi. 10.1634/theoncologist.2012-0206
- By:
- Publication type:
- Article
Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 80, doi. 10.1634/theoncologist.2012-0291
- By:
- Publication type:
- Article
Elderly Postmenopausal Patients With Breast Cancer Are at Increased Risk for Distant Recurrence: A Tamoxifen Exemestane Adjuvant Multinational Study Analysis.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 8, doi. 10.1634/theoncologist.2012-0315
- By:
- Publication type:
- Article
The Role of Palliative Surgery in Gynecologic Cancer Cases.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 73, doi. 10.1634/theoncologist.2012-0328
- By:
- Publication type:
- Article
Feasibility of Computer-Based Self-Administered Cancer-Specific Geriatric Assessment in Older Patients With Gastrointestinal Malignancy.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 64, doi. 10.1634/theoncologist.2012-0241
- By:
- Publication type:
- Article
Relative Effectiveness and Safety of Chemotherapy in Elderly and Nonelderly Patients With Stage III Colon Cancer: A Systematic Review.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 54, doi. 10.1634/theoncologist.2012-0050
- By:
- Publication type:
- Article
Efficient Allocation of Novel Agents in Multiple Myeloma: A Work in Progress.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 5, doi. 10.1634/theoncologist.2012-0484
- By:
- Publication type:
- Article
Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 46, doi. 10.1634/theoncologist.2012-0263
- By:
- Publication type:
- Article
Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel-Agent-Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real-World Claims Data.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 37, doi. 10.1634/theoncologist.2012-0113
- By:
- Publication type:
- Article
Reflections.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 1, doi. 10.1634/theoncologist.2013-1001
- Publication type:
- Article
The Cost-Effectiveness of Initial Treatment of Multiple Myelomain the U.S. With Bortezomib Plus Melphalan and Prednisone Versus Thalidomide Plus Melphalan and Prednisone or Lenalidomide Plus Melphalan and Prednisone With Continuous Lenalidomide...
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 27, doi. 10.1634/theoncologist.2011-0380
- By:
- Publication type:
- Article
CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 25, doi. 10.1634/theoncologist.2012-0211
- By:
- Publication type:
- Article
A Tale of Two Histiocytic Disorders.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 2, doi. 10.1634/theoncologist.2012-0440
- By:
- Publication type:
- Article
Hand-Schüller-Christian Disease and Erdheim-Chester Disease: Coexistence and Discrepancy.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 19, doi. 10.1634/theoncologist.2012-0234
- By:
- Publication type:
- Article
Tissue Factor as a Novel Target for Treatment of Breast Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 14, doi. 10.1634/theoncologist.2012-0322
- By:
- Publication type:
- Article
Musing in Oncology: When Oncology Meets Music Something Special Happens.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 112, doi. 10.1634/theoncologist.2012-0140
- By:
- Publication type:
- Article
Oncology Drug Development and Approval of Systemic Anticancer Therapy by the U.S. Food and Drug Administration.
- Published in:
- Oncologist, 2013, v. 18, n. 1, p. 104, doi. 10.1634/theoncologist.2012-0235
- By:
- Publication type:
- Article
Resolution: Refresh, Recharge, Renew.
- Published in:
- 2013
- By:
- Publication type:
- Editorial